This process is impacted by PI3K/AKT signalling pathway which is activated in both pancreatic ductal adenocarcinomas and neuroendocrine pancreatic tumours [91,92]. This evidence concerns the gene PIK3CG and pancreatic ductal adenocarcinoma.